CVD Risk Reduction and Lipid Management - 12

The Apo B-containing (non-HDL) Lipoprotein Family: All Atherogenic
LDL ApoB*

ApoB-containing lipoproteins1 – LDL—most common/most important – IDL – VLDL /VLDL remnants – Chylomicron remnants – Lp(a)
*ApoB is a component of all lipoprotein particles currently considered atherogenic2 Apo = apolipoprotein; IDL = intermediate-density lipoprotein; VLDL = very low-density lipoprotein; Lp(a) = lipoprotein (a) 1. Olofsson SO et al. Vasc Health Risk Manag. 2007;3:491-502. 2. Grundy SM. Circulation. 2002;106:2526-2529. 3. Kunitake ST et al. J Lipid Res. 1992;33:1807-1816. Images available at: http://www.mc.vanderbilt.edu/lens/article/?id=186&pg=999. Accessed January 2010. Adapted with permission.



CVD Risk Reduction and Lipid Management

Table of Contents for the Digital Edition of CVD Risk Reduction and Lipid Management

CVD Risk Reduction and Lipid Management - 3
CVD Risk Reduction and Lipid Management - 5
CVD Risk Reduction and Lipid Management - 6
CVD Risk Reduction and Lipid Management - 7
CVD Risk Reduction and Lipid Management - 8
CVD Risk Reduction and Lipid Management - 9
CVD Risk Reduction and Lipid Management - 10
CVD Risk Reduction and Lipid Management - 11
CVD Risk Reduction and Lipid Management - 12
CVD Risk Reduction and Lipid Management - 13
CVD Risk Reduction and Lipid Management - 14
CVD Risk Reduction and Lipid Management - 15
CVD Risk Reduction and Lipid Management - 16
CVD Risk Reduction and Lipid Management - 17
CVD Risk Reduction and Lipid Management - 18
CVD Risk Reduction and Lipid Management - 19
CVD Risk Reduction and Lipid Management - 20
CVD Risk Reduction and Lipid Management - 21
CVD Risk Reduction and Lipid Management - 22
CVD Risk Reduction and Lipid Management - 23
CVD Risk Reduction and Lipid Management - 24
CVD Risk Reduction and Lipid Management - 25
CVD Risk Reduction and Lipid Management - 26
CVD Risk Reduction and Lipid Management - 27
CVD Risk Reduction and Lipid Management - 28
CVD Risk Reduction and Lipid Management - 29
CVD Risk Reduction and Lipid Management - 30
CVD Risk Reduction and Lipid Management - 31
CVD Risk Reduction and Lipid Management - 32
CVD Risk Reduction and Lipid Management - 33
CVD Risk Reduction and Lipid Management - 34
CVD Risk Reduction and Lipid Management - 35
CVD Risk Reduction and Lipid Management - 36
CVD Risk Reduction and Lipid Management - 37
CVD Risk Reduction and Lipid Management - 38
CVD Risk Reduction and Lipid Management - 39
CVD Risk Reduction and Lipid Management - 40
CVD Risk Reduction and Lipid Management - 41
CVD Risk Reduction and Lipid Management - 42
CVD Risk Reduction and Lipid Management - 43
CVD Risk Reduction and Lipid Management - 44
CVD Risk Reduction and Lipid Management - 45
CVD Risk Reduction and Lipid Management - 46
CVD Risk Reduction and Lipid Management - 47
CVD Risk Reduction and Lipid Management - 48
CVD Risk Reduction and Lipid Management - 49
CVD Risk Reduction and Lipid Management - 50
CVD Risk Reduction and Lipid Management - 51
CVD Risk Reduction and Lipid Management - 52
CVD Risk Reduction and Lipid Management - 53
CVD Risk Reduction and Lipid Management - 54
CVD Risk Reduction and Lipid Management - 55
CVD Risk Reduction and Lipid Management - 56
CVD Risk Reduction and Lipid Management - 57
CVD Risk Reduction and Lipid Management - 58
CVD Risk Reduction and Lipid Management - 59
CVD Risk Reduction and Lipid Management - 60
CVD Risk Reduction and Lipid Management - 61
CVD Risk Reduction and Lipid Management - 62
CVD Risk Reduction and Lipid Management - 63
CVD Risk Reduction and Lipid Management - 64
CVD Risk Reduction and Lipid Management - 65
CVD Risk Reduction and Lipid Management - 66
https://www.nxtbookmedia.com